학술논문

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy
Document Type
Article
Source
In: Breast Cancer Research and Treatment. (Breast Cancer Research and Treatment, 1 April 2020, 180(3):647-655)
Subject
Language
English
ISSN
15737217
01676806